Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies

作者姓名：	Fowler J,Jarratt M,Moore A,Meadows K,Pollack A,Steinhoff M,Liu Y,Leoni M Brimonidine Phase II Study Group

摘要：
本文献已被 PubMed 等数据库收录！